Navigation Links
Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology
Date:8/22/2012

TAMPA, Florida, August 22, 2012 /PRNewswire/ --

Drug Class Overviews revamped to address the changing needs of health care professionals

Leading drug information provider Elsevier / Gold Standard announced today its new Drug Class Overviews, making Clinical Pharmacology more valuable at the point of care.

Clinical Pharmacology Drug Class Overviews are now even more powerful for evaluating formulary decisions and therapeutic drug substitutions.  Elsevier / Gold Standard has improved the speed and usability of the content through bulleted summaries and tables, highlighting a variety of critical areas in drug-interaction information.

"The new Drug Class Overviews represent a significant evolution in our content development that was stimulated and driven by input from our clients," said Elsevier / Gold Standard President Marianne Messer.  "This advancement also represents the way in which our users wish to utilize our vast amount of drug information that is updated in real-time."

The new Drug Class Overviews includes:

  • A summary in simple bullet format
  • Pharmacology/Mechanism of Action with key pharmacology and pharmacokinetics and tables to highlight differences
  • Therapeutic Use, highlighting place in therapy, alternatives within a class, and key clinical differences with labeled, off-label, and not recommended indications
  • Comparative Efficacy, highlighting randomized control trials for one or more indications
  • Adverse Reactions/Toxicities summarizes serious adverse events and toxicities
  • Drug Interactions, helping clinicians determine which drugs to use
  • Safety Issues, highligh
    '/>"/>

SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
4. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
5. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
8. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
9. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
10. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
11. Elsevier Launches New Journal: Learning, Culture and Social Interaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Senomyx , Inc. ... taste science technologies to discover, develop, and commercialize novel ... , Ph.D., the Company,s Vice President, Biology and ... Relations & Corporate Communications, will present an overview of ... 10:25 a.m. Eastern Time (7:25 a.m. Pacific Time) during ...
(Date:5/24/2013)... 2013 Vestiage, Inc. (stock symbol ... on science-based research and development, sales and marketing ... nutraceuticals, announced today that it is awarding exclusive ... sale of Reluma Skin Illuminating Facial Care. Qualified ... by sending an email to info(at)vestiageinc(dot)com and putting ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 2013 Patheon Inc ., a ... the global pharmaceutical industry, will host a complimentary webinar ... Testing” on Tuesday, June 4, 2013 at 11 a.m. ... required to comply with regulations for cleaning validation. ... scientific underpinning and little evaluation of risk. Some ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... Kill Human Embryos for Research, LANSING, Mich., ... Executive Officer Sister Monica Kostielney,R.S.M., made the following ... committee "Stem Cell Research BQC":, "In order ... stage, any,proposal, legislative or ballot related, that seeks ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, ... China, through its wholly owned subsidiary Jade,Pharmaceutical ... that,engages in the development, manufacture and marketing ... today that JPI has,signed an agreement with ...
... Compendia Bioscience, Inc.,today announced the receipt of a ... Cancer Institute to support the project entitled "Development,of ... and,Development". (Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO ) ... as the principal,investigator for this project, will assume ...
Cached Biology Technology:AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually 2Compendia Bioscience Announces the Receipt of a $2.4M SBIR Award and Related Management Changes 2
(Date:5/24/2013)... medication against Alzheimer,s disease, scientists have focused among other ... (A-beta). After all, it is the accumulation of A-beta that ... Starting point for the formation of A-beta is APP. Alessia ... unravel the function of APPL the fruit-fly version of ... , Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) ... among grasses , Within the genome of each ... undergo little change in position and sequence over millions ... Some of these evolutionarily stable sequences, so-called conserved noncoding ... other genes or the condensation of chromosomes, but the ...
(Date:5/23/2013)... Northwest National Laboratory honored more than 165 staff ... property at PNNL,s annual Intellectual Property Commercialization Recognition ... of Energy national laboratory named materials scientist Jun ... developing battery materials that can store large amounts ... and reduce the time it takes to charge ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... nuclear weapons remains a goal for governments around the ... 21st century, as recognised at the 2010 nuclear security ... efforts to prevent the proliferation of nuclear weapons, but ... the important role science in this field. A new ...
... A panel of scientists speaking today at the annual meeting ... unveiled new research and models demonstrating how climate change could ... coastal and Great Lakes ecosystems, with some studies projecting impacts ... the wettest year on record and third warmest for sea ...
... Researchers from the Georgia Institute of Technology have ... of people worldwide from dying of pneumonia each year. ... is a solution to the problem of diagnosing pneumonia, ... for Disease Control and Prevention (CDC). Pneumonia, an ...
Cached Biology News:Enhancing nuclear security: Training and international collaboration 2Climate projections show human health impacts possible within 30 years 2Climate projections show human health impacts possible within 30 years 3Climate projections show human health impacts possible within 30 years 4A better way to diagnose pneumonia 2A better way to diagnose pneumonia 3
Incorporating the innovative InGaAs detection system the Cary 6000i is the worlds most advanced UV-Vis-NIR spectrophotometer delivering superior signal to noise performance and outstanding sensitivit...
ABI 432 Resins • Gln(Trt) Peptide Synthesis Column...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
...
Biology Products: